Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017
BOCA RATON, Fla., April 27, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017 to discuss the […]
Causes of Basal Cell Carcinoma and Squamous Cell Carcinoma
This list of causes of basal cell carcinoma is by no means comprehensive. If you think you might have a basal cell carcinoma or a squamous cell carcinoma, speak with your doctor right away. Repeated or Over-Exposure to Ultraviolet Light Exposure to the sun’s rays (or from tanning beds) is considered to be the largest […]
Sensus Healthcare issues letter to stockholders
BOCA RATON, Fla., April 24, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that Joe Sardano, chairman and chief executive officer issued today the following letter to stockholders: Dear Fellow Stockholder: Our first annual stockholders’ […]
Alternative to Mohs Surgery: SRT-100™
Since the 1930s, doctors have successfully treated various forms of skin cancer, including basal cell carcinoma and squamous cell carcinoma, the most common forms of skin cancer, using Mohs micrographic surgery. Today, Mohs surgery is the most widely accepted and utilized treatment for skin cancer with cure rates of over 98%. However, there are many […]
